Trialled and true

Written by:

Colleen Seto

November 18, 2021

Teaser:

In celebration of the 25^th anniversary of the Canada Foundation for听Innovation (CFI), we are profiling one of our CFI Major Science Initiatives, The Canadian Cancer Trials Group.

Deck:

Clinical trials at Queen鈥檚 University help determine life-changing diagnostics, treatments and prevention methods for cancer. In celebration of the 25^th听anniversary of the Canada Foundation for听Innovation (CFI), we are profiling one of our CFI Major Science Initiatives, The Canadian Cancer Trials Group.

Cancer continues to be a leading cause of death in Canada and around the world. (CCTG), based at 澳门六合彩开奖现场, plays a critical role in the fight against cancer by designing and administering clinical trials in cancer therapy, supportive care, and prevention across Canada as a national program of the Canadian Cancer Society.

"Cancer touches everybody,"听says Dr. Janet Dancey, CCTG鈥檚 director. "Through clinical trials, we help reduce the burden of cancer by defining new standards of care, diagnostic tests and roles of therapies for different cancers."听Since its establishment in 1980, CCTG has supported more than 600 phase I-III trials enrolling approximately 100,000 patients from 40 countries on six continents. At any given time, CCTG has 60 to 70 active clinical trials.

Main text:

CCTG has grown to become the largest research group at Queen鈥檚 with a network of scientific leaders from all the cancer centres and hospitals in Canada and a global network of nearly 20,000 investigators and clinical trial staff. "We are capable of executing a whole range of trials for Canadians who have or may be at risk for cancer,"听says Dr. Dancey. "Where we distinguish ourselves is that we have the largest portfolio of cancer trials, a great track record and routinely engage international partners. We tend to be the academic organization that does the largest, the most complicated and the best executed clinical trials."

"CCTG is a huge point of pride for Queen鈥檚,"听affirms Dr. Nancy Ross, Vice-Principal (Research) at Queen鈥檚. "The dedication and professionalism of the CCTG team has led them to be a global leader in this important work. They have set the standard for expertise and quality in their ability to quickly get platforms in place to launch important trials that have real impact on medical treatments."

Putting together a clinical trial, especially a large one with thousands of participants, can be a monumental task. "There is nothing more collaborative than mounting a clinical trial,"听Dr. Dancey says. "You need investigators not just to lead the study, and to collect and analyze the data, but you need an army to organize and make sure it runs smoothly and you need patient volunteers willing to participate."

Main text:

This is true for drug trials, but also for trials examining non-pharmaceutical interventions that may improve cancer outcomes such as diet, lifestyle, surgery and psycho-social aspects. "Part of our mission is to do trials that wouldn鈥檛 be done by industry,"听Dr. Dancey says. While CCTG takes pride in global collaboration, it also pays particular attention to what鈥檚 pertinent to Canadians. "The best way to help Canadians is to focus on questions that are relevant to Canadian patients and our healthcare system."

Much of the work that takes place through CCTG has led to important treatments and continued research. One trial from 15 years ago showed that for lung cancer patients, chemotherapy improved survivorship after surgery. "That is still standard treatment now,"听Dr. Dancey affirms. "The trial is an example of how the Canadian lung cancer community is a leader. We help researchers to collaborate, be real leaders of trials testing Canadian-developed treatment ideas have the potential to become new treatments for patients across the world."

Similarly, a recent CCTG trial, published in 2021, was the first to show that stereotactic body radiation therapy (SBRT) is more effective than conventional radiation treatments in alleviating pain from spinal metastases. The study showed that using fewer and higher doses of precisely delivered SBRT is more effective than the standard treatment with 35 per cent of patients reporting an enduring, complete control of pain at three months post-radiation. "There鈥檚 been lots of uptake following the results of that trial being published, and it鈥檚 now considered the standard of care,"听says Dr. Dancey.

Main text:

Support from funders including the听听and the听Canada Foundation for Innovation (CFI) has been critical to the CCTG鈥檚 ability to have such impact.

听

"Prior to CFI funding, CCTG was at an inflection point,"听says Dr. Dancey. "Trial funding was limited, yet trial complexity had increased due to scientific advances and regulatory compliance requirements. CFI funding allowed us to continue to grow to conduct first-class research."

听

"The support of the CFI has been indispensable to the success of the CCTG,"听agrees Dr. Ross. "This global effort takes a great deal of operational and administrative coordination with hundreds of staff and faculty managing the processes from recruitment to analysis.听Ultimately, though, it鈥檚 important to remember that the CFI is investing in improved survival and quality of life for cancer patients."

听

"Originally published in the Excellence in Research and Innovation special feature in The Globe and Mail on November 19, 2021."

Centres and Institutes

Sinclair Cancer Research Institute

Core research:

The Sinclair Cancer Research Institute (SCRI) is driving global efforts to combat cancer through cutting-edge research, innovative facilities, clinical trials, and a program to train the next generation of cancer researchers.

Discovery: They explore new drugs and therapies, using basic science and advanced imaging to understand the body鈥檚 response to treatments.

Trials: Potential treatments are rigorously tested to establish new standards of care for specific cancers.

More about this Centre/Institute

Topics:

Advancing human health and wellbeing

Future skills and innovation

Custom Search Form